Sequential ATRA Then IL-2 for Modulation of Dendritic Cells and Treatment of Metastatic Renal Cell Cancer
Clinical trial NCT00100906 · COMPLETED
Trial details
- NCT number
- NCT00100906
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-08-01
- Primary completion
- 2006-06-01
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.